PT  - JOURNAL ARTICLE
AU  - Gram, Mie Agermose
AU  - Steenhard, Nina
AU  - Cohen, Arieh Sierra
AU  - Vangsted, Anne-Marie
AU  - Mølbak, Kåre
AU  - Gorm Jensen, Thøger
AU  - Hansen, Christian Holm
AU  - Ethelberg, Steen
TI  - Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up
AID  - 10.1101/2023.02.06.23285556
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.06.23285556
4099  - http://medrxiv.org/content/early/2023/02/13/2023.02.06.23285556.short
4100  - http://medrxiv.org/content/early/2023/02/13/2023.02.06.23285556.full
AB  - Background The Danish national SARS-CoV-2 mass test system was among the most ambitious worldwide. We describe its set-up and analyse differences in patterns of testing per demography and time period in relation to the three waves of SARS-CoV-2 transmission in Denmark.Methods We included all reported PCR- and rapid antigen-tests performed between 27 February 2020 and 10 March 2022 among all residents aged 2 years or above. Descriptive statistics and Poisson regression models were used to analyse characteristics of individuals tested for SARS-CoV-2 using a national cohort study design.Results A total of 63.7 million PCR-tests and 60.0 million antigen-tests were performed in the study period, testing 91.1% and 79.2% of the Danish population at least once by PCR or antigen, respectively. Female sex, younger age, Danish heritage and living in the capital area were all factors positively associated with the frequency of PCR-testing. The association between COVID-19 vaccination and PCR-testing changed from negative to positive over time.Conclusion We provide details of the widely available, free-of-charge, national SARS-CoV-2 test system, which served to identify infected individuals, assist isolation of infectious individuals and contact tracing, and thereby mitigating the spread of SARS-CoV-2 in the Danish population. The test system was utilized by nearly the entire population at least once, and widely accepted across different demographic groups. However, demographic differences in the test uptake did exist and should be considered in order not to cause biases in studies related to SARS-CoV-2, e.g., studies of transmission and vaccine effectiveness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data are available for research upon reasonable request and with permission from the Danish Data Protection Agency and Danish Health Data Authority. Ethics: We used only administrative register data for the study. According to Danish law, ethics approval is exempt for such research, and the Danish Data Protection Agency, which is a dedicated ethics and legal oversight body, thus waives ethical approval for our study of administrative register data, when no individual contact of participants is neccessary and only aggregate results are included as findings. The study is therefore fully compliant with all legal and ethical requirements and there are no further processes available regarding such studies.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data material used involve information on every person living in Denmark within the study period. Data cannot be shared publicly because they may only be accessed and register-coupled within a secure data analysis environment. However, de-identified participant-level data are available for Institutional Data access to members of the scientific and medical community for non-commercial use only. Applications should be submitted to Forskerservice (https://sundhedsdatastyrelsen.dk/da/forskerservice) at The Danish Health Data Authority, where they will be reviewed on the basis of relevance and scientific merit. Data are available now, with no defined end date. https://sundhedsdatastyrelsen.dk/da/forskerservice